The challenge of cancer and thromboembolic disease
Weighing the risks and benefits
of prophylaxis
Mary-Frances Scully, MD, FRCPC and Agnes Y.Y. Lee, MD, MSc, FRCPC

Review of important clinical trials with commentaries by Canadian experts
The 45th American Society of Clinical Oncology Annual Meeting
Bevacizumab in colon cancer
Stephen Welch, MD, FRCPC
Trastuzumab in advanced gastric cancer
Scot Dowden, MD, FRCPC
Treatment of triple-negative/BRCA1-associated breast cancer
Debjani Grenier, MD, FRCPC
Receptor crosstalk in metastatic breast cancer
Caroline Lohrisch, MD, FRCPC
Bevacizumab in metastatic breast cancer
Susan Dent, MD, BSc, FRCPC

Cover photo: Colon cancer blood supply • steve gschmeissner / SCIENCE PHOTO LIBRARY

Professional meetings roster
Your calendar dates for essential
conferences and symposia

New drugs and indications
A review of recent cancer therapy
approvals in Canada and the US